Mrs Stacey Anne Loose, MA CF-SLP | |
1451 Galway Dr, Alamogordo, NM 88310-7845 | |
(575) 495-2880 | |
Not Available |
Full Name | Mrs Stacey Anne Loose |
---|---|
Gender | Female |
Speciality | Qualified Speech Language Pathologist |
Experience | 4 Years |
Location | 1451 Galway Dr, Alamogordo, New Mexico |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629692629 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Gallien Inc | 6103808175 | 4 |
News Archive
Researchers from The Miriam Hospital have found that patients who have completed cardiac rehabilitation and who receive telephone counseling that supports exercise are more likely to adhere to an exercise program. Results of the study, funded by the National Heart, Lung and Blood Institute, are published in the American Journal of Preventive Medicine.
Hold the rose-coloured glasses: toddlers understand much more about false beliefs than parents and scientists previously suspected. A Canada-U.S. research team has discovered that very young children absolutely comprehend that other people believe things that aren't true.
A study exploring patterns of messages to anesthesiologists supervising care in operating rooms provides clues as to how hospitals might use "tele-anesthesia" technology to deploy anesthesia expertise and resources more efficiently, reports the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Fabre-Kramer Pharmaceuticals Inc. (FKP) and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the new drug application for gepirone extended- release (ER) tablets, submitted for the treatment of adults with major depressive disorder.
BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company at the forefront of global efforts towards the development of a Universal Influenza Vaccine, announced the successful conclusion of the Company's second Phase I/II clinical trial of the Multimeric-001 Universal Influenza Vaccine.
› Verified 8 days ago
Provider Name | Gallien Inc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1881768869 PECOS PAC ID: 6103808175 Enrollment ID: O20150921000853 |
News Archive
Researchers from The Miriam Hospital have found that patients who have completed cardiac rehabilitation and who receive telephone counseling that supports exercise are more likely to adhere to an exercise program. Results of the study, funded by the National Heart, Lung and Blood Institute, are published in the American Journal of Preventive Medicine.
Hold the rose-coloured glasses: toddlers understand much more about false beliefs than parents and scientists previously suspected. A Canada-U.S. research team has discovered that very young children absolutely comprehend that other people believe things that aren't true.
A study exploring patterns of messages to anesthesiologists supervising care in operating rooms provides clues as to how hospitals might use "tele-anesthesia" technology to deploy anesthesia expertise and resources more efficiently, reports the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Fabre-Kramer Pharmaceuticals Inc. (FKP) and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the new drug application for gepirone extended- release (ER) tablets, submitted for the treatment of adults with major depressive disorder.
BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company at the forefront of global efforts towards the development of a Universal Influenza Vaccine, announced the successful conclusion of the Company's second Phase I/II clinical trial of the Multimeric-001 Universal Influenza Vaccine.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Stacey Anne Loose, MA CF-SLP 5980 Highway 54 S Unit 3334, Alamogordo, NM 88311-9506 Ph: (575) 921-2408 | Mrs Stacey Anne Loose, MA CF-SLP 1451 Galway Dr, Alamogordo, NM 88310-7845 Ph: (575) 495-2880 |
News Archive
Researchers from The Miriam Hospital have found that patients who have completed cardiac rehabilitation and who receive telephone counseling that supports exercise are more likely to adhere to an exercise program. Results of the study, funded by the National Heart, Lung and Blood Institute, are published in the American Journal of Preventive Medicine.
Hold the rose-coloured glasses: toddlers understand much more about false beliefs than parents and scientists previously suspected. A Canada-U.S. research team has discovered that very young children absolutely comprehend that other people believe things that aren't true.
A study exploring patterns of messages to anesthesiologists supervising care in operating rooms provides clues as to how hospitals might use "tele-anesthesia" technology to deploy anesthesia expertise and resources more efficiently, reports the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Fabre-Kramer Pharmaceuticals Inc. (FKP) and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the new drug application for gepirone extended- release (ER) tablets, submitted for the treatment of adults with major depressive disorder.
BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company at the forefront of global efforts towards the development of a Universal Influenza Vaccine, announced the successful conclusion of the Company's second Phase I/II clinical trial of the Multimeric-001 Universal Influenza Vaccine.
› Verified 8 days ago
Adrienne Nicole Herrenbruck, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1211 Hawaii Ave, Alamogordo, NM 88310 Phone: 575-812-5977 | |
Ms. Carrie Lopez Balazs, M.ED, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2669 N. Scenic Dr., Gerald Champion Regional Medical Center, Alamogordo, NM 88310 Phone: 575-446-5526 | |
Soraya Cabrera-loeffler, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1211 Hawaii Ave, Alamogordo, NM 88310 Phone: 575-812-6000 | |
Margaret Doyle, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1211 Hawaii Ave, Alamogordo, NM 88310 Phone: 575-812-5977 | |
Mrs. Sarah Moralez, MS, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 805 12th St, Alamogordo, NM 88310 Phone: 575-812-5977 | |
Ms. Emma Grace Lindsey, MA, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2669 Scenic Dr, Alamogordo, NM 88310 Phone: 575-446-5534 | |
Speechbliss Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1461 Columbia Ave, Alamogordo, NM 88310 Phone: 575-404-9152 Fax: 877-311-5440 |